Welcome to our dedicated page for Inmode news (Ticker: INMD), a resource for investors and traders seeking the latest updates and insights on Inmode stock.
InMode Ltd. reports developments in medical-technology devices that use radiofrequency technology for minimally invasive and non-invasive aesthetic and medical procedures. Company updates commonly address product platforms and treatment categories for plastic surgery, dermatology, gynecology, otolaryngology and ophthalmology, including face and body contouring, medical aesthetics and women's health.
Recurring news also covers GAAP and non-GAAP financial results, consumables and service revenue, regional performance in the United States and Europe, margin trends, investor-conference participation, board-reviewed strategic matters and capital allocation actions such as ordinary-share repurchase programs.
Summary not available.
InMode (NASDAQ: INMD) plans to release its second quarter 2026 financial results before the Nasdaq market opens on Wednesday, August 5, 2026. Based on preliminary figures, management expects Q2 2026 revenue between $95.2 million and $95.4 million and reiterates full-year 2026 revenue guidance of $365 million to $375 million.
The company noted that these results are preliminary and subject to final adjustments. As a Special Committee continues evaluating strategic proposals, InMode will not hold an investor conference call, webcast, or investor meetings in connection with this earnings release.
InMode (NASDAQ: INMD) confirmed that its Board of Directors received an unsolicited letter and acquisition proposal from Steel Partners Holdings L.P. dated July 9, 2026.
A Special Committee of independent directors, supported by legal and financial advisors, will carefully review the proposal consistent with its fiduciary duties and states it is committed to acting in the best interests of all shareholders. The Special Committee does not intend to comment further at this time.
Summary not available.
DOMA Perpetual Capital Management, holding about 4.63% of InMode (NYSE: INMD), announced strong opposition to the CEO-led buyout at $16.20 per share and plans to vote against it. DOMA argues the offer undervalues InMode, cites governance and conflict-of-interest concerns, and urges a fully independent review and market check.
InMode (Nasdaq: INMD) announced that its board received an unsolicited proposal on June 17, 2026 from M.N. Business Strategy to acquire all outstanding ordinary shares it does not already own for $16.20 per share in cash via merger.
The board formed a special committee of independent directors to evaluate the proposal with advisors, in line with fiduciary duties. There is no assurance any transaction or strategic outcome will result, and the company expects to give no further updates unless legally required.
InMode (Nasdaq: INMD) announced key leadership changes effective immediately. Dr. Shlomo Nass was appointed Chairman of the Board, succeeding retired chairman Dr. Michael Anghel. InMode also promoted Moshik Itzkovich, formerly Senior Vice President of Finance, to Chief Financial Officer, replacing Yair Malca, who will remain as a consultant through the Annual General Meeting to support a smooth transition.
InMode (NASDAQ: INMD) announced participation in two upcoming investor events. Management will join the Barclays Virtual West Coast Bus Trip on May 20, featuring a virtual investor bus tour.
The company will also attend the Jefferies Global Healthcare Conference in New York on June 3, with an in-person fireside chat at 12:45 pm ET and one-on-one meetings. A live webcast of the presentation will be available.
InMode (Nasdaq: INMD) reported Q1 2026 GAAP revenue of $82.0 million, a 5% increase versus Q1 2025, with GAAP net income of $11.6 million ($0.18 diluted) and GAAP gross margin of 75%. Cash, equivalents and short-term investments totaled $537.2 million as of March 31, 2026. Management completed repurchase of 2.55 million shares ($34.8 million) and announced a CFO transition and a board chair change. Full-year 2026 guidance: revenue $365–375 million, non-GAAP gross margin 74–76%, non-GAAP operating income $73–78 million, non-GAAP EPS $1.33–1.38.
InMode (Nasdaq: INMD) expects to report first quarter 2026 results before market open on May 6, 2026, and will hold a conference call at 8:30 a.m. ET that day. Management currently expects Q1 revenue $81.5M–$81.7M and non‑GAAP gross margin 75%–76%. The company reiterated FY2026 revenue guidance $365M–$375M. Results are preliminary and subject to final adjustments; the call will be webcast with a replay available through May 20, 2026, and on the investor site for 90 days.